BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 10595780)

  • 21. Molecular basis of the nevoid basal cell carcinoma syndrome.
    Wicking C; Bale AE
    Curr Opin Pediatr; 1997 Dec; 9(6):630-5. PubMed ID: 9425597
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Elucidating the role of molecular signaling pathways in the tumorigenesis of basal cell carcinoma.
    Tang JY
    Semin Cutan Med Surg; 2011 Dec; 30(4 Suppl):S6-9. PubMed ID: 22177103
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nevoid basal cell carcinoma syndrome: molecular biology and new hypotheses.
    Cohen MM
    Int J Oral Maxillofac Surg; 1999 Jun; 28(3):216-23. PubMed ID: 10355946
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gamma-irradiation deregulates cell cycle control and apoptosis in nevoid basal cell carcinoma syndrome-derived cells.
    Fujii K; Miyashita T; Takanashi J; Sugita K; Kohno Y; Nishie H; Yasumoto S; Furue M; Yamada M
    Jpn J Cancer Res; 1999 Dec; 90(12):1351-7. PubMed ID: 10665653
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nevoid basal cell carcinoma syndrome.
    Leger M; Quintana A; Tzu J; Yee H; Kamino H; Sanchez M
    Dermatol Online J; 2011 Oct; 17(10):23. PubMed ID: 22031649
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A novel missense mutation in the PTCH1 gene in a premature case of nevoid basal cell carcinoma syndrome.
    Nakamura M; Tokura Y
    Eur J Dermatol; 2009; 19(3):262-3. PubMed ID: 19213655
    [No Abstract]   [Full Text] [Related]  

  • 27. A novel PTCH1 mutation in a patient of nevoid basal cell carcinoma syndrome.
    Honma M; Ohishi Y; Uehara J; Ibe M; Kinouchi M; Ishida-Yamamoto A; Iizuka H
    J Dermatol Sci; 2008 Apr; 50(1):73-5. PubMed ID: 18068337
    [No Abstract]   [Full Text] [Related]  

  • 28. PTCH1 +/- dermal fibroblasts isolated from healthy skin of Gorlin syndrome patients exhibit features of carcinoma associated fibroblasts.
    Valin A; Barnay-Verdier S; Robert T; Ripoche H; Brellier F; Chevallier-Lagente O; Avril MF; Magnaldo T
    PLoS One; 2009; 4(3):e4818. PubMed ID: 19287498
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Nevoid basal-cell carcinoma syndrome (Gorlin Syndrome): report of two cases and review of the literature].
    Castro-Mujica MDC; Barletta-Carrillo C; Poterico JA; Acosta M; Valer J; Cruz M
    Rev Peru Med Exp Salud Publica; 2017; 34(4):744-750. PubMed ID: 29364426
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Patched, hedgehog, and skin cancer.
    Quinn AG; Epstein E
    Methods Mol Biol; 2003; 222():85-95. PubMed ID: 12710681
    [No Abstract]   [Full Text] [Related]  

  • 31. Nevoid basal cell carcinoma syndrome.
    Gorlin RJ
    Dermatol Clin; 1995 Jan; 13(1):113-25. PubMed ID: 7712637
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gorlin syndrome: identification of 4 novel germ-line mutations of the human patched (PTCH) gene. Mutations in brief no. 137. Online.
    Hasenpusch-Theil K; Bataille V; Laehdetie J; Obermayr F; Sampson JR; Frischauf AM
    Hum Mutat; 1998; 11(6):480. PubMed ID: 10200051
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Unusual cystic scalp lesions in Gorlin syndrome: a brief report.
    Findley AB; Pride H
    Pediatr Dermatol; 2010; 27(2):204-7. PubMed ID: 20537080
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nevoid basal cell carcinoma syndrome: a review of the literature.
    Manfredi M; Vescovi P; Bonanini M; Porter S
    Int J Oral Maxillofac Surg; 2004 Mar; 33(2):117-24. PubMed ID: 15050066
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Heterozygous mutations in the tumor suppressor gene PATCHED provoke basal cell carcinoma-like features in human organotypic skin cultures.
    Brellier F; Bergoglio V; Valin A; Barnay S; Chevallier-Lagente O; Vielh P; Spatz A; Gorry P; Avril MF; Magnaldo T
    Oncogene; 2008 Nov; 27(51):6601-6. PubMed ID: 18679421
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel mutation in the PTCH1 gene in a patient with Gorlin syndrome with prominent clinical features.
    Valdivielso-Ramos M; Solera J; Mauleon C; Hernanz JM; Amiñoso C; Galiano S; De la Cueva P
    Clin Exp Dermatol; 2014 Apr; 39(3):406-7. PubMed ID: 24635088
    [No Abstract]   [Full Text] [Related]  

  • 37. Nevoid basal cell carcinoma syndrome or multiple hereditary infundibulocystic basal cell carcinoma syndrome?
    Crawford KM; Kobayashi T
    J Am Acad Dermatol; 2004 Dec; 51(6):989-95. PubMed ID: 15583598
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Fifth phakomatosis. The multiple nevoid basal cell carcinoma syndrome].
    Pineda M; Seguías C; Fábregues I; Asprer J; Fernández-Alvarez E
    Med Clin (Barc); 1983 Dec; 81(18):813-6. PubMed ID: 6656451
    [No Abstract]   [Full Text] [Related]  

  • 39. Unexpected manifestation of naevoid basal cell carcinoma (Gorlin) syndrome with a novel mutation in the PTCH1 gene in a female patient with long-lasting pemphigus vulgaris.
    Goetze S; Raessler F; Hipler UC; Schulz S; Kohlhase J; Elsner P
    J Eur Acad Dermatol Venereol; 2016 Mar; 30(3):493-4. PubMed ID: 25600101
    [No Abstract]   [Full Text] [Related]  

  • 40. [PTPC (Patched). Tumor suppressor gene].
    Soussi T; Basset-Seguin N
    Bull Cancer; 1999 Feb; 86(2):131-2. PubMed ID: 10094520
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.